1.
Aloufi LK, Almaysari RK, Aljehani AT, Mohammed D. AD, Alnefaie ZM. Pharmacological, behavioral, and sociocultural dimensions of GLP-1 and dual incretin therapies in Saudi Arabia: clinical evidence, misuse patterns, and policy priorities. Int J Basic Clin Pharmacol [Internet]. 2025 Dec. 23 [cited 2026 Jan. 27];15(1):158-65. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/6165